Studies of individuals with a genetic disease lacking coding mutations but with a non-coding genetic defect provided many insights into the function of cis-regulatory elements. An example of this is FOXL2, encoding a forkhead transcription factor playing a role in ovarian development. Here we aim to dissect the cis-regulatory landscape of FOXL2 and to identify and validate ovary-specific enhancers